The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -15,878 | -12,618 | -11,966 | -31,598 |
| Prepaid expenses | -4,350 | 4,150 | -4,200 | 300 |
| Accounts payable | -5,094 | 356 | -7,357 | 12,164 |
| Related party payables | -13,748 | - | 1,817 | 19,450 |
| Accrued expense | 2,726 | 2,625 | 1,891 | -1,226 |
| Net cash used in operating activities | -6,377 | -35,054 | -11,415 | -1,510 |
| Note payable related party | - | 33,767 | 12,500 | - |
| Net cash provided by investing activities | 0 | - | - | 0 |
| Net cash provided by financing activities | 10,000 | 33,767 | 12,500 | 0 |
| Net change in cash | 3,623 | -1,287 | 1,085 | -1,510 |
| Cash at beginning of period | 661 | 1,948 | 2,373 | - |
| Cash at end of period | 4,284 | 661 | 1,948 | - |
Nu-Med Plus, Inc. (NUMD)
Nu-Med Plus, Inc. (NUMD)